Biotech Firm Adagene Plans $200 Million U.S. IPO

(Bloomberg) -- Adagene Inc., a Chinese biotechnology company backed by WuXi AppTec Co. and private equity firm General Atlantic, is planning a U.S. initial public offering that could raise about $2...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.